Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer

Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial

(2010) S. Riethdorf et al.   CLINICAL CANCER RESEARCH

Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients

(2009) Marta Pestrin et al.   BREAST CANCER RESEARCH AND TREATMENT

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer

(2009) Seigo Nakamura et al.   Breast Cancer

Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance

(2008) Stella Apostolaki et al.   BREAST CANCER RESEARCH AND TREATMENT

Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies

(2008) Mitra Tewes et al.   BREAST CANCER RESEARCH AND TREATMENT

Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer

(2008) M. Ignatiadis et al.   CLINICAL CANCER RESEARCH

Evaluation of circulating tumor cells in patients with breast cancer: multi-institutional clinical trial in Japan

(2008) Hiroshi Yagata et al.   International Journal of Clinical Oncology